Skip to content

Gen 2 Battrode Wear Study

Gen 2 Battrode Wear Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07256951
Enrollment
30
Registered
2025-12-01
Start date
2025-11-12
Completion date
2026-05-15
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive Wear Time

Brief summary

Validating adhesive wear time

Interventions

DEVICEAdhesive

14 day wear

Sponsors

Baxter Healthcare Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Participant is ≥ 18 years. 2. Completes the consent process as required. 3. Participants can speak and read English fluently. 4. Willing to allow shaving of device application area, as required. 5. Willing to take photos of the application area before wear, daily during wear, and immediately after removal. 6. Willingness to report current known pregnancy.

Exclusion criteria

1. Unable to comply with the study protocol and instructions for wearing the devices for up to 15 days. 2. Any pre-existing breached or compromised skin, skin rash, irritation or infection at the application area. 3. Any incision, wound or scar in the application area. 4. Participants with known skin allergies and sensitivities to adhesives. 5. Participants with scheduled electronic imaging (including magnetic resonance imaging), cardioversion, and/or procedures where device would be removed during the data collection period. 6. Participants with known history of cardiac arrhythmias. 7. Participants with chest anatomies not compatible with secure parasternal placement. 8. Use of clothing or garment that can dislodge or loosen the patch or bras with underwires or other worn items that might interfere with the devices under study.

Design outcomes

Primary

MeasureTime frame
Wear time15 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026